PARTIAL INSULIN RECEPTOR AGONIST, COMPOSITION, INSULIN ANALOG AND INSULIN ANALOG DIMERS, METHOD FOR TREATMENT OF DIABETES, USES OF A PARTIAL INSULIN RECEPTOR AGONIST AND A COMPOUND, AND, COMPOUND.
Номер патента: BR112017010481A8
Опубликовано: 11-04-2023
Автор(ы): B Madsen-Duggan Christina, Feng Danqing, Huo Pei, Kekec Ahmet, LIN SONGNIAN, Mu Yingjun, Nargund Ravi, Pissarnitski Dmitri, Shi Zhi-Cai, Wu Zhicai, Yan Lin, Zhu Yuping
Принадлежит: Merck Sharp & Dohme, Merck Sharp & Dohme LLC
Опубликовано: 11-04-2023
Автор(ы): B Madsen-Duggan Christina, Feng Danqing, Huo Pei, Kekec Ahmet, LIN SONGNIAN, Mu Yingjun, Nargund Ravi, Pissarnitski Dmitri, Shi Zhi-Cai, Wu Zhicai, Yan Lin, Zhu Yuping
Принадлежит: Merck Sharp & Dohme, Merck Sharp & Dohme LLC
Реферат: AGONISTA PARCIAL DE RECEPTOR DE INSULINA, COMPOSIÇÃO, COMPOSTO, DÍMERO DE INSULINA, MÉTODO PARA TRATAR DIABETES, e, USO DE UM COMPOSTO. São descritos dímeros de insulina e dímeros de análogos de insulina que atuam como agonistas parciais no receptor de insulina. PARTIAL INSULIN RECEPTOR AGONIST, COMPOSITION, COMPOUND, INSULIN DIMER, METHOD FOR TREATMENT OF DIABETES, and, USE OF A COMPOUND. Insulin dimers and insulin analogue dimers that act as partial agonists at the insulin receptor are described.
Methods for diagnosis and treatment of MDK1 signal transduction disorders
Номер патента: US20060099708A1. Автор: Axel Ullrich,Thomas Ciossek,Birgit Millauer. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2006-05-11.